Unilever and Innova Partnerships one step closer to self-cleaning surfaces
London - Unilever and Innova Partnerships have launched a joint venture biotechnology company, Penrhos Bio, to commercialise a technology that means self-cleaning surfaces could become a reality.
The world first breakthrough has come with the introduction of an organic compound called Lactam which can block, or prevent, bacteria and mould on everyday surfaces.
This patented technology, which Unilever has been researching for over 10 years, is developed from natural chemicals in seaweed biology and has the potential to be used in a range of situations - from preventing fungal growth in washing machines and dishwashers to self-cleaning banknotes.
Everyday items including clothing and kitchen surfaces are constantly challenged by bacterial contamination. Over 80% of bacterial infections in people are estimated to involve the formation of biofilms, a collection of microorganisms that grows on many surfaces. These microorganisms are formed and developed through bacterial communications systems, but now research has found that by disrupting these systems it’s possible to not only prevent them from growing in the first place but to keep the surfaces cleaner for longer.
Penhros Bio could help to tackle some of the biggest societal and environmental challenges of the 21st century. It represents significant opportunity across multiple sectors, including healthcare, textiles, and marine and could even be used in medical fields where microbial biofilms are commonplace.
Dr Neil Parry, R&D Programme Director - Biotechnology and Biosourcing, Unilever, explained: “This technology replicates the natural cleaning process of seaweed; keeping surfaces clean and repelling unwanted invaders from its direct environment. This biology works in extreme conditions such that it will keep working in dirty waters by blocking the communication between bacteria so that it cannot colonise and build up on healthy surfaces of the plant. This is what we have successfully replicated in the lab, and now we are ready to start trialling this in our Unilever cleaning products.”
Dr Jon Hague, Unilever’s Vice President for Science & Technology, Unilever Homecare said: “The commercialised use of Lactam presents a significant opportunity for cleaning products globally and could revolutionise the industry. However, what we have found is a unique technology in which its uses are almost limitless. We recognise what this technology can represent at scale for many sectors outside of Unilever’s portfolio. Through Penrhos Bio, we want to connect with other industries that would benefit from using this solution.”
Professor Steve Howell, Founder of Innova Partnerships said: “This is such an exciting and innovative space. We’re currently working with license partners for banknotes and dental applications, but there are so many more uses in which this technology could benefit.”
Notes to Editors:
Penrhos Bio offers this technology to license across a range of sectors. Penrhos Bio business model is to develop relationships with licence partners across a range of sectors such as machine cleaning, marine, textiles and healthcare. Discussions are already underway with licence partners for banknote and dental applications. Penrhos Bio is supported by Unilever operating out of the Materials Innovation Factory in Liverpool, UK.
About Innova Partnerships
Founded in 2006, Innova Partnerships Ltd is a boutique consultancy that supports the growth and commercial development of health care companies. Innova specialise in early-stage businesses support from fund raising, team building and strategic partnering all the way through to positioning companies for exit. Over the last 14 years, Innova has supported well over 50 companies and has advised U.K. government development agencies with high growth companies across the U.K. The company is based in Scotland.
Where relevant, these actions are subject to the appropriate consultations and approvals.
This announcement may contain forward-looking statements, including ‘forward-looking statements’ within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as ‘will’, ‘aim’, ‘expects’, ‘anticipates’, ‘intends’, ‘looks’, ‘believes’, ‘vision’, or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the ‘Group’). They are not historical facts, nor are they guarantees of future performance.
Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever’s global brands not meeting consumer preferences; Unilever’s ability to innovate and remain competitive; Unilever’s investment choices in its portfolio management; the effect of climate change on Unilever’s business; Unilever’s ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic.
These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Further details of potential risks and uncertainties affecting the Group are described in the Group’s filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Unilever Annual Report and Accounts 2020.